{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
TruBridge, Inc.
TruBridge, Inc. Stock Hits New 52-Week Low at $14.67
TruBridge, Inc., a microcap healthcare services company, has reached a new 52-week low, contrasting with its previous high. Despite this decline, the company has shown a notable annual performance increase, significantly exceeding the S&P 500. TruBridge's financial metrics indicate moderate leverage and a focus on growth reinvestment.
TruBridge, Inc. Hits New 52-Week Low at $14.81 Amid Market Volatility
TruBridge, Inc., a microcap healthcare services company, recently hit a 52-week low of USD 14.81, contrasting with a high of USD 29.78. Despite this volatility, the company has achieved a 54.71% performance increase over the past year, significantly outperforming the S&P 500. Its market cap is USD 266 million.
TruBridge, Inc. Stock Plummets to New 52-Week Low of $15.55
TruBridge, Inc., a microcap healthcare services company, has reached a new 52-week low, reflecting recent stock volatility. Despite this, it has shown a notable performance increase over the past year. The company has a market capitalization of USD 266 million and operates with a P/E ratio of 24.00.
TruBridge, Inc. Hits New 52-Week Low at $17.75
TruBridge, Inc., a microcap healthcare services company, recently hit a 52-week low of USD 17.75, following a peak of USD 32 earlier this year. Despite this volatility, it has achieved an impressive one-year performance of 84.94%, significantly surpassing the S&P 500's growth. The company has a market cap of USD 306 million and is currently loss-making.
TruBridge, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Metrics
TruBridge, Inc., a microcap in healthcare services, has adjusted its valuation, showing a P/E ratio of 27.58 and a negative return on equity of -2.57%. Compared to peers, its financial metrics reveal mixed results, with notable declines in stock performance over the past year.
Is TruBridge, Inc. technically bullish or bearish?
As of August 12, 2025, TruBridge, Inc. is in a mildly bearish trend due to negative indicators, despite outperforming the S&P 500 in the short term with returns of 3.73% and 10.70% over the past week and month, respectively, while significantly underperforming over three years with a return of -26.17%.
Is TruBridge, Inc. overvalued or undervalued?
As of November 8, 2023, TruBridge, Inc. is considered overvalued with a negative return on equity of -5.10% and a price-to-book value of 2.14, indicating a risky valuation compared to peers like MediaAlpha and OneSpan, despite a recent strong return of 75.06% over the past year.
Is TruBridge, Inc. overvalued or undervalued?
As of November 8, 2023, TruBridge, Inc. is considered overvalued with a risky valuation grade, reflected by key ratios indicating it trades at a premium compared to earnings potential and struggles with negative ROE and low ROCE compared to peers, despite a strong one-year stock return of 118.60%.
Is TruBridge, Inc. technically bullish or bearish?
As of April 1, 2025, TruBridge, Inc. shows a mildly bullish trend supported by daily moving averages, but caution is advised due to mildly bearish weekly MACD and KST indicators.
Who are in the management team of TruBridge, Inc.?
As of March 2022, the management team of TruBridge, Inc. includes Glenn Tobin (Independent Chair), John Boyd Douglas (President & CEO), David Dye (Director & Chief Growth Officer), and several Independent Directors: Regina Benjamin, Christopher Hjelm, Charles Huffman, and W. Austin Mulherin. This team combines executive leadership with independent oversight to guide the company.
What does TruBridge, Inc. do?
TruBridge, Inc. provides healthcare IT solutions for rural and community hospitals and post-acute care facilities, with recent net sales of $87 million and a market cap of $349.63 million. The company is currently loss-making, with a debt-to-equity ratio of 0.94 and a return on equity of -5.10%.
How big is TruBridge, Inc.?
As of Jun 18, TruBridge, Inc. has a market capitalization of 349.63 million and net sales of 343.13 million, with a net profit of -19.38 million for the latest four quarters. Shareholder's funds are 168.69 million and total assets are 420.59 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
